USD 55.0
(-4.35%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 7.42 Million USD | -41.06% |
2022 | 12.6 Million USD | -3.08% |
2021 | 13 Million USD | -6.93% |
2020 | 13.97 Million USD | 44.25% |
2019 | 9.68 Million USD | 30.74% |
2018 | 7.41 Million USD | -15.07% |
2017 | 8.72 Million USD | -11.9% |
2016 | 9.9 Million USD | 30.96% |
2015 | 7.56 Million USD | 21.53% |
2014 | 6.22 Million USD | 22.88% |
2013 | 5.06 Million USD | 52.05% |
2012 | 3.33 Million USD | 0.0% |
2010 | 4.56 Million USD | 1.86% |
2009 | 4.47 Million USD | 0.0% |
2006 | 4.63 Million USD | 14.06% |
2005 | 4.06 Million USD | 2.39% |
2004 | 3.97 Million USD | 8.28% |
2003 | 3.66 Million USD | 9.93% |
2002 | 3.33 Million USD | 0.0% |
2000 | 2.88 Million USD | 14.87% |
1999 | 2.5 Million USD | -6.24% |
1998 | 2.67 Million USD | 27.05% |
1997 | 2.1 Million USD | 3.53% |
1996 | 2.03 Million USD | 12.97% |
1995 | 1.8 Million USD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q1 | 437.27 Thousand USD | 191.41% |
2023 Q4 | -478.34 Thousand USD | -120.38% |
2023 Q3 | 2.34 Million USD | -7.45% |
2023 Q1 | 3.02 Million USD | 209.97% |
2023 Q2 | 2.53 Million USD | -16.12% |
2022 Q3 | 323.7 Thousand USD | -91.11% |
2022 Q2 | 3.64 Million USD | -1.69% |
2022 Q1 | 3.7 Million USD | 56.34% |
2022 FY | 8.64 Million USD | -33.53% |
2022 Q4 | 975.53 Thousand USD | 201.36% |
2021 Q4 | 2.36 Million USD | -26.86% |
2021 FY | 13 Million USD | -6.93% |
2021 Q3 | 3.23 Million USD | -13.29% |
2021 Q1 | 3.66 Million USD | -0.37% |
2021 Q2 | 3.73 Million USD | 2.02% |
2020 Q1 | 3.94 Million USD | -28.01% |
2020 Q3 | 2.85 Million USD | -18.14% |
2020 Q4 | 3.67 Million USD | 28.52% |
2020 FY | 13.97 Million USD | 44.25% |
2020 Q2 | 3.49 Million USD | -11.5% |
2019 FY | 9.68 Million USD | 30.74% |
2019 Q3 | 2.3 Million USD | -12.89% |
2019 Q1 | 3.01 Million USD | -38.28% |
2019 Q4 | 5.48 Million USD | 138.02% |
2019 Q2 | 2.64 Million USD | -12.24% |
2018 Q3 | 1.85 Million USD | -6.23% |
2018 Q1 | 2 Million USD | 19.9% |
2018 FY | 7.41 Million USD | -15.07% |
2018 Q4 | 4.88 Million USD | 162.92% |
2018 Q2 | 1.98 Million USD | -1.33% |
2017 Q3 | 2.25 Million USD | -3.96% |
2017 FY | 8.72 Million USD | -11.9% |
2017 Q1 | 2.51 Million USD | -49.32% |
2017 Q2 | 2.34 Million USD | -6.54% |
2017 Q4 | 1.67 Million USD | -25.73% |
2016 Q1 | 2.83 Million USD | 37.54% |
2016 FY | 9.9 Million USD | 30.96% |
2016 Q3 | 1.45 Million USD | -17.04% |
2016 Q4 | 4.95 Million USD | 239.47% |
2016 Q2 | 1.75 Million USD | -37.87% |
2015 FY | 7.56 Million USD | 21.53% |
2015 Q4 | 2.05 Million USD | -2.38% |
2015 Q3 | 2.1 Million USD | -0.86% |
2015 Q2 | 2.12 Million USD | 55.57% |
2015 Q1 | 1.36 Million USD | 19.59% |
2014 Q4 | 1.14 Million USD | -26.04% |
2014 FY | 6.22 Million USD | 22.88% |
2014 Q1 | 1.62 Million USD | 2.64% |
2014 Q2 | 1.9 Million USD | 17.21% |
2014 Q3 | 1.54 Million USD | -18.92% |
2013 FY | 5.06 Million USD | 52.05% |
2013 Q4 | 1.58 Million USD | 26.56% |
2013 Q2 | 1.13 Million USD | 4.42% |
2013 Q3 | 1.25 Million USD | 10.09% |
2013 Q1 | 1.08 Million USD | 23.48% |
2012 Q3 | 349.91 Thousand USD | -64.2% |
2012 Q4 | 882.21 Thousand USD | 152.12% |
2012 Q2 | 977.52 Thousand USD | 0.0% |
2012 FY | 3.33 Million USD | 0.0% |
2011 Q1 | 1.48 Million USD | 7.98% |
2010 FY | 4.56 Million USD | 1.86% |
2010 Q4 | 1.37 Million USD | 24.17% |
2010 Q3 | 1.1 Million USD | -0.81% |
2010 Q1 | 972.55 Thousand USD | -16.52% |
2010 Q2 | 1.11 Million USD | 14.44% |
2009 FY | 4.47 Million USD | 0.0% |
2009 Q4 | 1.16 Million USD | 17.21% |
2009 Q3 | 993.89 Thousand USD | -1.0% |
2009 Q2 | 1 Million USD | 0.0% |
2006 Q3 | 1.33 Million USD | 34.33% |
2006 Q4 | 953.74 Thousand USD | -28.57% |
2006 Q2 | 993.98 Thousand USD | -26.59% |
2006 Q1 | 1.35 Million USD | 55.81% |
2006 FY | 4.63 Million USD | 14.06% |
2005 Q3 | 1.05 Million USD | 18.15% |
2005 Q2 | 892.38 Thousand USD | -28.59% |
2005 FY | 4.06 Million USD | 2.39% |
2005 Q1 | 1.24 Million USD | 0.0% |
2005 Q4 | 868.98 Thousand USD | -17.58% |
2004 FY | 3.97 Million USD | 8.28% |
2003 FY | 3.66 Million USD | 9.93% |
2002 FY | 3.33 Million USD | 0.0% |
2001 Q1 | 735.82 Thousand USD | -9.8% |
2001 Q2 | 690.36 Thousand USD | -6.18% |
2001 Q3 | 741.5 Thousand USD | 7.41% |
2000 Q4 | 815.73 Thousand USD | 4.48% |
2000 FY | 2.88 Million USD | 14.87% |
2000 Q3 | 780.74 Thousand USD | 16.43% |
2000 Q2 | 670.55 Thousand USD | 9.11% |
2000 Q1 | 614.58 Thousand USD | -17.06% |
1999 FY | 2.5 Million USD | -6.24% |
1999 Q4 | 740.99 Thousand USD | 21.7% |
1999 Q2 | 581.67 Thousand USD | 0.0% |
1999 Q3 | 608.88 Thousand USD | 4.68% |
1998 FY | 2.67 Million USD | 27.05% |
1997 FY | 2.1 Million USD | 3.53% |
1996 FY | 2.03 Million USD | 12.97% |
1995 FY | 1.8 Million USD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
American Bio Medica Corporation | -193 Thousand USD | 3949.292% |
Arrayit Corporation | 2.57 Million USD | -188.504% |
Atlantic International Corp. | -154.23 Thousand USD | 4916.793% |
Biocept, Inc. | -2.58 Million USD | 387.728% |
CardioGenics Holdings Inc | - USD | -Infinity% |
DermTech, Inc. | 276 Thousand USD | -2591.715% |
Global WholeHealth Partners Corporation | - USD | -Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 6.73 Billion USD | 99.89% |
HTG Molecular Diagnostics, Inc. | 1.79 Million USD | -314.09% |
iMD Companies, Inc. | -23.63 Thousand USD | 31530.101% |
IDenta Corp. | 662.97 Thousand USD | -1020.575% |
Interpace Biosciences, Inc. | 23.04 Million USD | 67.76% |
Integrative Health Technologies, Inc. | 77.57 Thousand USD | -9477.204% |
InVitro International | 635.98 Thousand USD | -1068.13% |
Lumos Diagnostics Holdings Limited | 6.56 Million USD | -13.197% |
Many Bright Ideas Technologies Inc. | - USD | -Infinity% |
Medical Imaging Corp. | 1.09 Million USD | -579.898% |
NovelStem International Corp. | 12 Thousand USD | -61809.442% |
Optigenex Inc. | -102.96 Thousand USD | 7315.132% |
PharmChem, Inc. | 3.9 Million USD | -90.277% |
Proteome Sciences plc | 2.09 Million USD | -254.337% |
Response Genetics, Inc | 3.94 Million USD | -88.461% |
Rennova Health, Inc. | 6.26 Million USD | -18.52% |
RushNet, Inc. | 1.1 Million USD | -572.554% |
ScreenPro Security Inc. | 856.57 Thousand USD | -767.308% |
Stella Diagnostics Inc. | - USD | -Infinity% |
StageZero Life Sciences Ltd. | -403.74 Thousand USD | 1940.047% |
Todos Medical Ltd. | 4.31 Million USD | -72.37% |